Panagiota Sylla

University of Birmingham - Institute of Immunology and Immunotherapy

Birmingham

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS

492

SSRN CITATIONS

0

CROSSREF CITATIONS

1

Scholarly Papers (4)

1.

Booster Vaccination Strongly Enhances SARS-CoV-2-Specific Antibody and Cellular Responses in Elderly Residents of Care Homes

Number of pages: 20 Posted: 20 Dec 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 177 (239,252)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Vaccination, Booster, Care home, Long Term Care Facility (LTCF), Elderly

2.

Profile of Humoral and Cellular Immune Responses to Single BNT162b2 or ChAdOx1 Vaccine in Residents and Staff Within Residential Care Homes (VIVALDI Study)

Number of pages: 17 Posted: 04 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - UCL Institute of Health Informatics, University College London - Institute for Health Informatics, University College London - UCL Institute of Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 163 (256,380)
Citation 2

Abstract:

Loading...

3.

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities

Number of pages: 29 Posted: 09 Dec 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 139 (291,456)

Abstract:

Loading...

Long Term Care Facility, Resident, COVID-19, SARS-CoV-2, Vaccination

4.

Vaccine Subtype and Dose Interval Determine Immunogenicity of Primary Series COVID-19 Vaccines in Older People

Number of pages: 29 Posted: 27 Apr 2022
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 13 (776,987)

Abstract:

Loading...

COVID-19, vaccines, elderly, primary series, BNT162b2, ChAdOx1